𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Valganciclovir-Induced Leukopenia in Liver Transplant Recipients: Influence of Concomitant Use of Mycophenolate Mofetil

✍ Scribed by E. Molina Perez; J. Fernández Castroagudín; S. Seijo Ríos; J. Mera Calviño; S. Tomé Martínez de Rituerto; E. Otero Antón; M. Bustamante Montalvo; E. Varo Perez

Book ID
116935135
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
104 KB
Volume
41
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of mycophenolate mofeti
Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
✍ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req

Optimization of the dosing regimen of my
Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients
✍ Caroline Barau; Aurélie Barrail-Tran; Bogdan Hemerziu; Dalila Habes; Anne-Marie 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 1 views

Mycophenolate mofetil (MMF) is now commonly used in pediatric liver transplant recipients, but no clear recommendations about the dosing regimen have been made for this population. The aim of this study was to determine the MMF dosage required for pediatric liver transplant recipients to achieve an